We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

36 hedge funds and large institutions have $2.59M invested in Oncolytics Biotech in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more capital invested

Capital invested by funds: $1.46M → $2.59M (+$1.13M)

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

0.56% more ownership

Funds ownership: 1.95% → 2.51% (+0.56%)

0% more funds holding

Funds holding: 36 → 36 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

Holders
36
Holders Change
–
Holders Change %
0%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$387K
2
Marshall Wace
Marshall Wace
United Kingdom
+$270K
3
MWNA
Marshall Wace North America
New York
+$142K
4
IAIM
International Assets Investment Management
Florida
+$65.6K
5
VF
Virtu Financial
New York
+$46.9K

Top Sellers

Rank Fund Capital Flow
1
WS
Wedbush Securities
California
-$189K
2
JP Morgan Chase
JP Morgan Chase
New York
-$101K
3
Citadel Advisors
Citadel Advisors
Florida
-$39K
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$9.58K
5
CCM
Chiron Capital Management
Florida
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
1
Creative Planning
Kansas
$428K +$24K +10,000 +6%
Renaissance Technologies
2
Renaissance Technologies
New York
$415K +$387K +161,635 +1,284%
Two Sigma Advisers
3
Two Sigma Advisers
New York
$298K +$7.91K +3,300 +3%
IAIM
4
International Assets Investment Management
Florida
$287K +$65.6K +27,365 +29%
Marshall Wace
5
Marshall Wace
United Kingdom
$268K +$270K +112,594 New
CIBC World Market
6
CIBC World Market
Ontario, Canada
$148K +$3.12K +1,304 +2%
MWNA
7
Marshall Wace North America
New York
$141K +$142K +59,300 New
Morgan Stanley
8
Morgan Stanley
New York
$90K +$34.2K +14,270 +61%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$84K +$11.9K +4,963 +16%
Bank of America
10
Bank of America
North Carolina
$50K +$25.1K +10,462 +99%
VF
11
Virtu Financial
New York
$47K +$46.9K +19,587 New
Comerica Bank
12
Comerica Bank
Texas
$40K – – –
FDCDDQ
13
Federation des caisses Desjardins du Quebec
Quebec, Canada
$38.5K -$9.58K -4,000 -20%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$38K – – –
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
$37K +$9.78K +4,082 +42%
LPL Financial
16
LPL Financial
California
$27K -$4.79K -2,000 -15%
UCFA
17
United Capital Financial Advisors
Texas
$25K – – –
PAG
18
Private Advisor Group
New Jersey
$24K -$1.26K -526 -5%
CGA
19
Crescent Grove Advisors
Illinois
$24K – – –
Toronto Dominion Bank
20
Toronto Dominion Bank
Ontario, Canada
$18K +$17.8K +7,413 +2,309%
CMA
21
Cedar Mountain Advisors
Oregon
$13K – – –
IA
22
IFP Advisors
Florida
$12K – – –
TCOV
23
Trust Company of Vermont
Vermont
$12K – – –
Rockefeller Capital Management
24
Rockefeller Capital Management
New York
$8K – – –
Osaic Holdings
25
Osaic Holdings
Arizona
$7K -$161 -67 -2%
1
2

ONCY Hedge Fund Activity: Q4 2020 in Review

36 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q4 2020, worth a combined $2.59M — up 77% from $1.46M a quarter earlier.

Fund positioning in ONCY was balanced in Q4 2020: 6 funds opened new positions, 6 closed out, 10 added to existing stakes and 6 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $387K. The largest seller was Wedbush Securities, exiting entirely with an estimated $189K sold.

  • 36 institutional investors held Oncolytics Biotech (ONCY) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $2.59M of Oncolytics Biotech stock for Q4 2020, up 77% quarter-over-quarter.
  • 6 funds opened new Oncolytics Biotech positions in Q4 2020 and 6 closed out, a net change of 0 holders.
  • The largest Oncolytics Biotech buyer in Q4 2020 was Renaissance Technologies, an estimated $387K added.
  • The largest Oncolytics Biotech seller in Q4 2020 was Wedbush Securities, an estimated $189K sold.

Based on aggregated 13F filings for Q4 2020.